Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA

被引:31
|
作者
Peletskaya, EN
Kogon, AA
Tuske, S
Arnold, E
Hughes, SH
机构
[1] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA
[2] NCI, SAIC Frederick, Frederick, MD 21702 USA
[3] Rutgers State Univ, Dept Chem & Biol Chem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
关键词
D O I
10.1128/JVI.78.7.3387-3397.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Site-directed photoaffinity cross-linking experiments were performed by using human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) mutants with unique cysteine residues at several positions (i.e., positions 65, 67, 70, and 74) in the fingers subdomain of the p66 subunit. Since neither the introduction of the unique cysteine residues into the fingers nor the modification of the SH groups of these residues with photoaffinity cross-linking reagents caused a significant decrease in the enzymatic activities of RT, we were able to use this system to measure distances between specific positions in the fingers domain of RT and double-stranded DNA. HIV-1 RT is quite flexible. There are conformational changes associated with binding of the normal substrates and nonnucleoside RT inhibitors (NNRTIs). Cross-linking was used to monitor intramolecular movements associated with binding of an NNRTI either in the presence or in the absence of an incoming deoxynucleoside triphosphate (dNTP). Binding an incoming dNTP at the polymerase active site decreased the efficiency of cross-linking but caused only modest changes in the preferred positions of cross-linking. This finding suggests that the fingers of p66 are closer to an extended template in the "open" configuration of the enzyme with the fingers away from the active site than in the closed configuration with the fingers in direct contact with the incoming dNTP. NNRTI binding caused increased cross-linking in experiments with diazirine reagents (especially with a diazirine reagent with a longer linker) and a moderate shift in the preferred sites of interaction with the template. Cross-linking occurred closer to the polymerase active site for RTs modified at positions 70 and 74. The effects of NNRTI binding were more pronounced in the absence of a bound dNTP; pretreatment of HIV-1 RT with an NNRTI reduced the effect of dNTP binding. These observations can be explained if the binding of NNRTI causes a decrease in the flexibility in the fingers subdomain of RT-NNRTI complex and a decrease in the distance from the fingers to the template extension.
引用
收藏
页码:3387 / 3397
页数:11
相关论文
共 50 条
  • [1] Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor
    Pilon, AA
    Lum, JJ
    Sanchez-Dardon, J
    Phenix, BN
    Douglas, R
    Badley, AD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2687 - 2691
  • [2] Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer
    Peletskaya, EN
    Boyer, PL
    Kogon, AA
    Clark, P
    Kroth, H
    Sayer, JM
    Jerina, DM
    Hughes, SH
    JOURNAL OF VIROLOGY, 2001, 75 (19) : 9435 - 9445
  • [3] Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
    Fletcher, P.
    Harman, S.
    Azijn, H.
    Armanasco, N.
    Manlow, P.
    Perumal, D.
    de Bethune, M.-P.
    Nuttall, J.
    Romano, J.
    Shattock, R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 487 - 495
  • [4] In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor
    Sato, Akihiko
    Hammond, Jennifer
    Alexander, Therese N.
    Graham, Joanne P.
    Binford, Susan
    Sugita, Ken-ichi
    Sugimoto, Hirohiko
    Fujiwara, Tamio
    Patick, Amy K.
    ANTIVIRAL RESEARCH, 2006, 70 (02) : 66 - 74
  • [5] TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1
    Andries, K
    Azijn, H
    Thielemans, T
    Ludovici, D
    Kukla, M
    Heeres, J
    Janssen, P
    De Corte, B
    Vingerhoets, J
    Pauwels, R
    de Béthune, MP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4680 - 4686
  • [6] Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1
    Corbau, Romuald
    Mori, Julie
    Phillips, Chris
    Fishburn, Lesley
    Martin, Alex
    Mowbray, Charles
    Panton, Wendy
    Smith-Burchnell, Caroline
    Thornberry, Adele
    Ringrose, Heather
    Knoechel, Thorsten
    Irving, Steve
    Westby, Mike
    Wood, Anthony
    Perros, Manos
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4451 - 4463
  • [7] Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase
    Zhang, Zhijun
    Walker, Michelle
    Xu, Wen
    Shim, Jae Hoon
    Girardet, Jean-Luc
    Hamatake, Robert K.
    Hong, Zhi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2772 - 2781
  • [8] Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
    Gupta, Soumi
    Fransen, Signe
    Paxinos, Ellen E.
    Stawiski, Eric
    Huang, Wei
    Petropoulos, Christos J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 1973 - 1980
  • [9] Etravirine: A novel nonnucleoside reverse transcriptase inhibitor for managing human immunodeficiency virus infection
    Elsayed, Raghda K.
    Caldwell, David J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (03) : 193 - 205
  • [10] Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor
    Isaka, Y
    Sato, A
    Kawauchi, S
    Suyama, A
    Miki, S
    Hayami, M
    Fujiwara, T
    MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (03) : 195 - 202